Neurocrine Biosciences Inc (NASDAQ:NBIX) appears in 706 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 12,830,597 | 124,367 | 0.98% | $1,819,763,595.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,700,301 | -6,258 | -0.06% | $1,375,793,692.00 |
| DODGE & COX | 31 Dec, 2025 | 5,508,042 | -48,576 | -0.87% | $781,205,597.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 5,200,356 | -4,259,948 | -45.03% | $737,566,619.00 |
| State Street Corp | 31 Dec, 2025 | 4,242,681 | -103,798 | -2.39% | $601,739,446.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 3,271,706 | 498,058 | 17.96% | $462,651,883.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 2,238,797 | -179,500 | -7.42% | $317,528,579.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,059,282 | 34,457 | 1.70% | $291,341,652.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 1,744,560 | -67,202 | -3.71% | $247,430,944.00 |
| Bellevue Group AG | 31 Dec, 2025 | 1,703,304 | -59,801 | -3.39% | $241,579,606.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 1,395,902 | 447,869 | 47.24% | $197,989.00 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,291,278 | 88,522 | 7.36% | $178,248,014.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,221,184 | 295,470 | 31.92% | $173,200,527.00 |
| Morgan Stanley | 31 Dec, 2025 | 1,209,378 | -617,559 | -33.80% | $171,526,511.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Dec, 2025 | 1,184,345 | 0 | 0.00% | $167,975,651.00 |
| Swedbank AB | 31 Dec, 2025 | 1,168,258 | 620,929 | 113.45% | $165,694,032.00 |
| NORGES BANK | 31 Dec, 2025 | 1,146,896 | 1,146,896 | 0.00% | $162,664,260.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 1,062,072 | 0 | 0.00% | $150,633,672.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 984,811 | 637,246 | 183.35% | $139,675,744.00 |
| UBS Group AG | 31 Dec, 2025 | 983,528 | 618,956 | 169.78% | $139,493,777.00 |